Kawasaki disease or Kawasaki‐like disease: Influence of SARS‐CoV‐2 infections in Japan
Kazuki Iio, Kazuhiro Uda, Hiroshi Hataya, Fumihiko Yasui, Tomoko Honda, Takahiro Sanada, Kenzaburo Yamaji, Michinori Kohara, Masanari Itokawa, Masaru Miura
Abstract
The authors have no conflicts of interest relevant to this article to disclose. The intravenous immune globulin preparations used in this study were provided by Japan Blood Products Organization. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
Kawasaki diseaseMedicineDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPediatricsVirologyInfectious disease (medical specialty)PathologyInternal medicineOutbreakArteryKawasaki Disease and Coronary ComplicationsMechanical Circulatory Support DevicesCoronary Artery Anomalies